These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 6426396

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [FT-207 and 5-FU concentrations in brain tumor tissues, plasma and CSF after administration of FT-207 suppository].
    Matsuura H, Nakazawa S.
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):912-6. PubMed ID: 6426399
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of intravenous administration of FT-207 for gastric cancer].
    Otani Y, Yamanaka T, Kikuchi H, Namatame K, Yoshida K, Kataba Y, Maruyama Y, Watanabe H.
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):857-60. PubMed ID: 3920970
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Evaluation of chemotherapy of breast cancer (2). Clinical evaluation of the blood and tissue concentrations of FT-207 following intrarectal administration].
    Hiraide H, Mimura K, Kawano M, Hatsuse K, Kadota T, Kurokawa T, Tamaki K, Kanabe S, Mizoguchi O, Terashima H, Iwasa H.
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):992-6. PubMed ID: 6408994
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Thermotherapy for cancer of the urinary bladder in combination with tegafur suppository and picibanil--concentrations of tegafur in the serum and tissues in bladder carcinoma].
    Murahashi I, Mukae K, Tabata Y, Sakuma H, Kanbe K, Arai T, Kaneko K, Honda M, Maeda S, Takasaki E.
    Gan To Kagaku Ryoho; 1985 May; 12(5):1152-5. PubMed ID: 3922314
    [Abstract] [Full Text] [Related]

  • 13. [Pre- and intra-operative chemotherapy using FT-207 suppositories--with special reference to lung cancer].
    Fukuda K, Komatubara S, Sato G, Teramoto S.
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2212-5. PubMed ID: 6307181
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Fundamental studies on the introduction of chemotherapy of uterine cervical carcinoma--tissue level of 5-FU after oral administration].
    Hattori K, Hareyama H, Ishizaki Y, Ohkubo H, Kanemoto T.
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2193-9. PubMed ID: 6486834
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical evaluation of Tegafur suppository in the treatment of uterine cancer--with special reference to the drug concentration in the blood, secretion from the pelvic dead space, and tissues of female genital organs].
    Yamada E.
    Igaku Kenkyu; 1982 Nov; 52(5):269-87. PubMed ID: 6821182
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Serum concentration of 5-FU and tegafur (FT-207) after administration of tegafur (FT-207) suppository with the colostomy].
    Kimoto M, Nagano H, Gunge N, Murei T, Iwamoto S, Seo Y, Yamamoto Y, Sano K.
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2853-8. PubMed ID: 3116942
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.